IONS logo

Ionis Pharmaceuticals (IONS) Cash from financing

annual CFF:

$478.06M-$166.02M(-25.78%)
December 31, 2024

Summary

  • As of today (May 29, 2025), IONS annual cash flow from financing activities is $478.06 million, with the most recent change of -$166.02 million (-25.78%) on December 31, 2024.
  • During the last 3 years, IONS annual CFF has risen by +$232.13 million (+94.39%).
  • IONS annual CFF is now -25.78% below its all-time high of $644.08 million, reached on December 31, 2023.

Performance

IONS Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

quarterly CFF:

$2.20M+$46.31M(+104.98%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS quarterly cash flow from financing activities is $2.20 million, with the most recent change of +$46.31 million (+104.98%) on March 31, 2025.
  • Over the past year, IONS quarterly CFF has dropped by -$21.37 million (-90.67%).
  • IONS quarterly CFF is now -99.56% below its all-time high of $496.05 million, reached on September 30, 2024.

Performance

IONS quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

TTM CFF:

$456.69M-$21.37M(-4.47%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS TTM cash flow from financing activities is $456.69 million, with the most recent change of -$21.37 million (-4.47%) on March 31, 2025.
  • Over the past year, IONS TTM CFF has increased by +$281.12 million (+160.12%).
  • IONS TTM CFF is now -29.09% below its all-time high of $644.08 million, reached on December 31, 2023.

Performance

IONS TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

IONS Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-25.8%-90.7%+160.1%
3 y3 years+94.4%+130.0%+85.5%
5 y5 years+378.0%+102.3%+946.7%

IONS Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-25.8%+964.6%-99.6%+104.3%-29.1%+780.2%
5 y5-year-25.8%+180.1%-99.6%+100.4%-29.1%+176.6%
alltimeall time-25.8%+180.1%-99.6%+100.4%-29.1%+176.6%

IONS Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.20M(-105.0%)
$456.69M(-4.5%)
Dec 2024
$478.06M(-25.8%)
-$44.12M(-108.9%)
$478.06M(-15.1%)
Sep 2024
-
$496.05M(>+9900.0%)
$562.90M(+1527.6%)
Jun 2024
-
$2.56M(-89.2%)
$34.58M(-80.3%)
Mar 2024
-
$23.57M(-42.1%)
$175.56M(-72.7%)
Dec 2023
$644.08M(-1264.8%)
$40.72M(-226.2%)
$644.08M(+16.6%)
Sep 2023
-
-$32.27M(-122.5%)
$552.34M(-5.8%)
Jun 2023
-
$143.54M(-70.8%)
$586.44M(+32.0%)
Mar 2023
-
$492.09M(-1064.5%)
$444.12M(-903.2%)
Dec 2022
-$55.30M(-122.5%)
-$51.02M(-2881.8%)
-$55.30M(-17.2%)
Sep 2022
-
$1.83M(+50.9%)
-$66.77M(-0.6%)
Jun 2022
-
$1.22M(-116.6%)
-$67.14M(-127.3%)
Mar 2022
-
-$7.33M(-88.3%)
$246.19M(+0.1%)
Dec 2021
$245.93M(-141.2%)
-$62.49M(-4386.0%)
$245.93M(-215.4%)
Sep 2021
-
$1.46M(-99.5%)
-$213.06M(+4.7%)
Jun 2021
-
$314.54M(-4251.3%)
-$203.58M(-60.1%)
Mar 2021
-
-$7.58M(-98.5%)
-$509.69M(-14.6%)
Dec 2020
-$596.61M(-696.5%)
-$521.48M(-4868.0%)
-$596.61M(+967.2%)
Sep 2020
-
$10.94M(+29.7%)
-$55.90M(-30.1%)
Jun 2020
-
$8.44M(-108.9%)
-$80.02M(+48.3%)
Mar 2020
-
-$94.50M(-591.6%)
-$53.94M(-153.9%)
Dec 2019
$100.02M(-79.0%)
$19.23M(-245.9%)
$100.02M(+10.6%)
Sep 2019
-
-$13.17M(-138.2%)
$90.44M(-19.0%)
Jun 2019
-
$34.51M(-42.0%)
$111.69M(-78.9%)
Mar 2019
-
$59.46M(+516.4%)
$530.10M(+11.4%)
Dec 2018
$475.87M(+107.7%)
$9.65M(+19.4%)
$475.87M(+1.1%)
Sep 2018
-
$8.08M(-98.2%)
$470.48M(-22.9%)
Jun 2018
-
$452.92M(+8570.0%)
$609.97M(+284.2%)
Mar 2018
-
$5.22M(+22.7%)
$158.76M(-30.7%)
Dec 2017
$229.09M(+1910.6%)
$4.26M(-97.1%)
$229.09M(-0.9%)
Sep 2017
-
$147.57M(+8519.9%)
$231.28M(+162.1%)
Jun 2017
-
$1.71M(-97.7%)
$88.25M(+2.5%)
Mar 2017
-
$75.55M(+1071.6%)
$86.06M(+655.3%)
Dec 2016
$11.39M(-53.9%)
$6.45M(+41.9%)
$11.39M(-31.6%)
Sep 2016
-
$4.54M(-1054.4%)
$16.66M(+35.6%)
Jun 2016
-
-$476.00K(-154.2%)
$12.28M(-12.7%)
Mar 2016
-
$879.00K(-92.5%)
$14.08M(-43.1%)
Dec 2015
$24.73M(-58.5%)
$11.71M(+6914.4%)
$24.73M(-60.7%)
Sep 2015
-
$167.00K(-87.3%)
$62.89M(-2.4%)
Jun 2015
-
$1.32M(-88.6%)
$64.41M(+4.2%)
Mar 2015
-
$11.53M(-76.9%)
$61.80M(+3.7%)
Dec 2014
$59.59M(-73.8%)
$49.88M(+2865.6%)
$59.59M(+357.2%)
Sep 2014
-
$1.68M(-230.6%)
$13.03M(-54.6%)
Jun 2014
-
-$1.29M(-113.8%)
$28.71M(-87.4%)
Mar 2014
-
$9.31M(+179.9%)
$227.99M(+0.1%)
Dec 2013
$227.72M(+482.0%)
$3.33M(-80.8%)
$227.72M(+2.0%)
Sep 2013
-
$17.36M(-91.2%)
$223.25M(-7.1%)
Jun 2013
-
$197.99M(+2087.8%)
$240.29M(+380.3%)
Mar 2013
-
$9.05M(-886.3%)
$50.03M(+27.9%)
Dec 2012
$39.13M(-5922.9%)
-$1.15M(-103.3%)
$39.13M(-4.2%)
Sep 2012
-
$34.40M(+344.6%)
$40.87M(+632.2%)
Jun 2012
-
$7.74M(-517.5%)
$5.58M(-410.6%)
Mar 2012
-
-$1.85M(-416.8%)
-$1.80M(+167.4%)
Dec 2011
-$672.00K(-114.3%)
$585.00K(-165.9%)
-$672.00K(-147.4%)
Sep 2011
-
-$888.00K(-347.4%)
$1.42M(-25.6%)
Jun 2011
-
$359.00K(-149.3%)
$1.91M(-51.2%)
Mar 2011
-
-$728.00K(-127.2%)
$3.90M(-17.0%)
Dec 2010
$4.70M(-97.7%)
$2.67M(-767.1%)
$4.70M(+3.0%)
Sep 2010
-
-$401.00K(-117.0%)
$4.56M(-55.1%)
Jun 2010
-
$2.35M(+3361.8%)
$10.15M(+16.8%)
Mar 2010
-
$68.00K(-97.3%)
$8.69M(-95.7%)
Dec 2009
$202.00M(+87.8%)
$2.54M(-51.1%)
$202.00M(-3.2%)
Sep 2009
-
$5.19M(+482.4%)
$208.78M(+1.5%)
Jun 2009
-
$891.00K(-99.5%)
$205.74M(-10.6%)
Mar 2009
-
$193.38M(+1975.4%)
$230.02M(+113.8%)
Dec 2008
$107.58M
$9.32M(+333.4%)
$107.58M(+6.5%)
Sep 2008
-
$2.15M(-91.5%)
$101.02M(-9.5%)
Jun 2008
-
$25.17M(-64.5%)
$111.67M(+3349.8%)
DateAnnualQuarterlyTTM
Mar 2008
-
$70.95M(+2480.0%)
$3.24M(-92.6%)
Dec 2007
$43.65M(-70.8%)
$2.75M(-78.5%)
$43.65M(-62.4%)
Sep 2007
-
$12.80M(-115.4%)
$116.19M(+8.5%)
Jun 2007
-
-$83.27M(-174.8%)
$107.05M(-58.8%)
Mar 2007
-
$111.36M(+47.9%)
$260.04M(+74.0%)
Dec 2006
$149.46M(+297.5%)
$75.29M(+1957.6%)
$149.46M(+108.3%)
Sep 2006
-
$3.66M(-94.8%)
$71.76M(-34.7%)
Jun 2006
-
$69.73M(+8771.4%)
$109.88M(+205.3%)
Mar 2006
-
$786.00K(-132.6%)
$35.99M(-4.3%)
Dec 2005
$37.60M(+209.4%)
-$2.41M(-105.8%)
$37.60M(-18.2%)
Sep 2005
-
$41.77M(-1105.6%)
$45.95M(+596.0%)
Jun 2005
-
-$4.15M(-273.5%)
$6.60M(-51.1%)
Mar 2005
-
$2.39M(-59.7%)
$13.50M(+11.1%)
Dec 2004
$12.15M(-71.0%)
$5.94M(+145.5%)
$12.15M(-45.4%)
Sep 2004
-
$2.42M(-11.8%)
$22.24M(-13.9%)
Jun 2004
-
$2.74M(+161.7%)
$25.84M(-25.3%)
Mar 2004
-
$1.05M(-93.5%)
$34.59M(-17.4%)
Dec 2003
$41.85M(-67.7%)
$16.03M(+166.3%)
$41.85M(-23.0%)
Sep 2003
-
$6.02M(-47.6%)
$54.34M(+19.6%)
Jun 2003
-
$11.49M(+38.2%)
$45.44M(-64.9%)
Mar 2003
-
$8.31M(-70.8%)
$129.43M(-0.1%)
Dec 2002
$129.59M(-45.3%)
$28.51M(-1090.0%)
$129.59M(-43.5%)
Sep 2002
-
-$2.88M(-103.0%)
$229.21M(-27.0%)
Jun 2002
-
$95.49M(+1027.0%)
$314.17M(+28.0%)
Mar 2002
-
$8.47M(-93.4%)
$245.40M(+3.5%)
Dec 2001
$237.04M(+92.9%)
$128.13M(+56.1%)
$237.04M(+87.1%)
Sep 2001
-
$82.08M(+207.2%)
$126.70M(+180.4%)
Jun 2001
-
$26.72M(>+9900.0%)
$45.18M(-19.4%)
Mar 2001
-
$116.00K(-99.3%)
$56.07M(-54.4%)
Dec 2000
$122.88M(+92.3%)
$17.79M(+3110.8%)
$122.88M(-6.8%)
Sep 2000
-
$554.00K(-98.5%)
$131.80M(-7.0%)
Jun 2000
-
$37.62M(-43.8%)
$141.64M(+8.7%)
Mar 2000
-
$66.93M(+150.7%)
$130.33M(+104.0%)
Dec 1999
$63.90M(+323.2%)
$26.70M(+156.7%)
$63.90M(+70.4%)
Sep 1999
-
$10.40M(-60.5%)
$37.50M(+41.5%)
Jun 1999
-
$26.30M(+5160.0%)
$26.50M(+85.3%)
Mar 1999
-
$500.00K(+66.7%)
$14.30M(-5.3%)
Dec 1998
$15.10M(-58.9%)
$300.00K(-150.0%)
$15.10M(-62.6%)
Sep 1998
-
-$600.00K(-104.3%)
$40.40M(-4.0%)
Jun 1998
-
$14.10M(+984.6%)
$42.10M(+12.0%)
Mar 1998
-
$1.30M(-94.9%)
$37.60M(+2.5%)
Dec 1997
$36.70M(+59.6%)
$25.60M(+2227.3%)
$36.70M(+10.2%)
Sep 1997
-
$1.10M(-88.5%)
$33.30M(+4.7%)
Jun 1997
-
$9.60M(+2300.0%)
$31.80M(+37.1%)
Mar 1997
-
$400.00K(-98.2%)
$23.20M(+0.9%)
Dec 1996
$23.00M(-54.1%)
$22.20M(-5650.0%)
$23.00M(-16.1%)
Sep 1996
-
-$400.00K(-140.0%)
$27.40M(-44.0%)
Jun 1996
-
$1.00M(+400.0%)
$48.90M(-3.6%)
Mar 1996
-
$200.00K(-99.2%)
$50.70M(+1.2%)
Dec 1995
$50.10M(+1254.1%)
$26.60M(+26.1%)
$50.10M(+115.9%)
Sep 1995
-
$21.10M(+653.6%)
$23.20M(+866.7%)
Jun 1995
-
$2.80M(-800.0%)
$2.40M(-260.0%)
Mar 1995
-
-$400.00K(+33.3%)
-$1.50M(-140.5%)
Dec 1994
$3.70M(-90.7%)
-$300.00K(-200.0%)
$3.70M(-85.7%)
Sep 1994
-
$300.00K(-127.3%)
$25.80M(-3.0%)
Jun 1994
-
-$1.10M(-122.9%)
$26.60M(-1.8%)
Mar 1994
-
$4.80M(-78.0%)
$27.10M(-32.1%)
Dec 1993
$39.90M(-2760.0%)
$21.80M(+1881.8%)
$39.90M(+138.9%)
Sep 1993
-
$1.10M(-283.3%)
$16.70M(+10.6%)
Jun 1993
-
-$600.00K(-103.4%)
$15.10M(-7.9%)
Mar 1993
-
$17.60M(-1357.1%)
$16.40M(-1193.3%)
Dec 1992
-$1.50M(-102.3%)
-$1.40M(+180.0%)
-$1.50M(-105.0%)
Sep 1992
-
-$500.00K(-171.4%)
$30.30M(-1.0%)
Jun 1992
-
$700.00K(-333.3%)
$30.60M(-41.6%)
Mar 1992
-
-$300.00K(-101.0%)
$52.40M(-18.8%)
Dec 1991
$64.50M
$30.40M(<-9900.0%)
$64.50M(+89.1%)
Sep 1991
-
-$200.00K(-100.9%)
$34.10M(-0.6%)
Jun 1991
-
$22.50M(+90.7%)
$34.30M(+190.7%)
Mar 1991
-
$11.80M
$11.80M

FAQ

  • What is Ionis Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals annual CFF year-on-year change?
  • What is Ionis Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals quarterly CFF year-on-year change?
  • What is Ionis Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals TTM CFF year-on-year change?

What is Ionis Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of IONS is $478.06M

What is the all time high annual CFF for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high annual cash flow from financing activities is $644.08M

What is Ionis Pharmaceuticals annual CFF year-on-year change?

Over the past year, IONS annual cash flow from financing activities has changed by -$166.02M (-25.78%)

What is Ionis Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of IONS is $2.20M

What is the all time high quarterly CFF for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high quarterly cash flow from financing activities is $496.05M

What is Ionis Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, IONS quarterly cash flow from financing activities has changed by -$21.37M (-90.67%)

What is Ionis Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of IONS is $456.69M

What is the all time high TTM CFF for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high TTM cash flow from financing activities is $644.08M

What is Ionis Pharmaceuticals TTM CFF year-on-year change?

Over the past year, IONS TTM cash flow from financing activities has changed by +$281.12M (+160.12%)
On this page